Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

NCT00441740 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Vinorelbine
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Gemcitabine

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]